Use of spliceosome mediated RNA trans-splicing to confer cell selective replication to adenoviruses

Details for Australian Patent Application No. 2003302216 (hide)

Owner INTRONN, INC.

Inventors Otto, Edward

Agent Davies Collison Cave

Pub. Number AU-A-2003302216

PCT Number PCT/US2003/0148

PCT Pub. Number WO2004/050680

Priority 60/378,690 08.05.02 US

Filing date 8 May 2003

Wipo publication date 23 June 2004

Event Publications

15 July 2004 Complete Application Filed

  Priority application(s): 60/378,690 08.05.02 US

29 July 2004 Application Open to Public Inspection

  Published as AU-A-2003302216

3 January 2008 Assignment before Grant

  Intronn, Inc. The application has been assigned to VIRxSYS Corporation 2004

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003302217-Variant integrin polypeptides and uses thereof

2003302215-METHOD AND APPARATUS FOR CONTROL OF CHEMICAL OR BIOLOGICAL WARFARE AGENTS